An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection

Clinical trial NCT04522986 · COMPLETED

Trial details

NCT number: NCT04522986
Sponsor: Rohto Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2

Start date: 2020-08-21
Primary completion: 2021-02-02
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.